Literature DB >> 15385741

Frequent human leukocyte antigen class I alleles are associated with higher viral load among HIV type 1 seroconverters in Thailand.

Lily Nguyen1, Thanyanan Chaowanachan, Suphak Vanichseni, Janet M McNicholl, Philip A Mock, Robert Nelson, Thomas W Hodge, Frits van Griensven, Kachit Choopanya, Timothy D Mastro, Jordan W Tappero, Dale J Hu.   

Abstract

The loss of viral control by the host may be due to the evolution of viruses with mutations that limit presentation by human leukocyte antigen (HLA) to cytotoxic T cells. The authors hypothesized that the consequence of such evolution might be that persons with common HLA class I alleles would be less able to control viremia, on average, than would those with rare alleles. HLA class I typing was completed for 128 injection drug users who seroconverted in a prospective cohort study in Bangkok, Thailand. Logistic regression was used to model viral load (greater than or equal to the median) at 9 and 12 months after seroconversion with an HLA score that profiled the relative prevalence of each individual's alleles. At 12 months after seroconversion, injection drug users with the most common HLA alleles (highest quartile HLA score) had an almost 4-fold increased risk for higher viral load (> or = 32,055 copies/mL) than injection drug users with less common HLA alleles (adjusted odds ratio, 3.92; 95% confidence interval, 1.3-11.8). These findings support the importance of frequency-dependent effects of host genes on HIV type 1 evolution in different populations and suggest that HLA-driven viral evolution critically influences control of viremia in early HIV type 1 infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15385741     DOI: 10.1097/01.qai.0000127059.98621.55

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  10 in total

1.  Identification of immunogenic HLA-B7 "Achilles' heel" epitopes within highly conserved regions of HIV.

Authors:  Anne S De Groot; Daniel S Rivera; Julie A McMurry; Soren Buus; William Martin
Journal:  Vaccine       Date:  2007-12-26       Impact factor: 3.641

2.  Conservation of HIV-1 T cell epitopes across time and clades: validation of immunogenic HLA-A2 epitopes selected for the GAIA HIV vaccine.

Authors:  Lauren Levitz; Ousmane A Koita; Kotou Sangare; Matthew T Ardito; Christine M Boyle; John Rozehnal; Karamoko Tounkara; Sounkalo M Dao; Youssouf Koné; Zoumana Koty; Soren Buus; Leonard Moise; William D Martin; Anne S De Groot
Journal:  Vaccine       Date:  2012-10-24       Impact factor: 3.641

3.  The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected women.

Authors:  Mark H Kuniholm; Xiaojiang Gao; Xiaonan Xue; Andrea Kovacs; Darlene Marti; Chloe L Thio; Marion G Peters; Ruth M Greenblatt; James J Goedert; Mardge H Cohen; Howard Minkoff; Stephen J Gange; Kathryn Anastos; Melissa Fazzari; Mary A Young; Howard D Strickler; Mary Carrington
Journal:  J Infect Dis       Date:  2011-06-15       Impact factor: 5.226

4.  The influence of human leukocyte antigen class I alleles and their population frequencies on human immunodeficiency virus type 1 control among African Americans.

Authors:  Aleksandr Lazaryan; Wei Song; Elena Lobashevsky; Jianming Tang; Sadeep Shrestha; Kui Zhang; Janet M McNicholl; Lytt I Gardner; Craig M Wilson; Robert S Klein; Anne Rompalo; Kenneth Mayer; Jack Sobel; Richard A Kaslow
Journal:  Hum Immunol       Date:  2011-01-21       Impact factor: 2.850

5.  MHC heterozygote advantage in simian immunodeficiency virus-infected Mauritian cynomolgus macaques.

Authors:  Shelby L O'Connor; Jennifer J Lhost; Ericka A Becker; Ann M Detmer; Randall C Johnson; Caitlin E Macnair; Roger W Wiseman; Julie A Karl; Justin M Greene; Benjamin J Burwitz; Benjamin N Bimber; Simon M Lank; Jennifer J Tuscher; Edward T Mee; Nicola J Rose; Ronald C Desrosiers; Austin L Hughes; Thomas C Friedrich; Mary Carrington; David H O'Connor
Journal:  Sci Transl Med       Date:  2010-03-10       Impact factor: 17.956

6.  Human leukocyte antigen genotype and risk of HIV disease progression before and after initiation of antiretroviral therapy.

Authors:  Mark H Kuniholm; Xiaojiang Gao; Xiaonan Xue; Andrea Kovacs; Kathryn Anastos; Darlene Marti; Ruth M Greenblatt; Mardge H Cohen; Howard Minkoff; Stephen J Gange; Melissa Fazzari; Mary A Young; Howard D Strickler; Mary Carrington
Journal:  J Virol       Date:  2011-08-17       Impact factor: 5.103

7.  Rare HLA drive additional HIV evolution compared to more frequent alleles.

Authors:  Christine M Rousseau; David W Lockhart; Jennifer Listgarten; Stephen N Maley; Carl Kadie; Gerald H Learn; David C Nickle; David E Heckerman; Wenjie Deng; Christian Brander; Thumbi Ndung'u; Hoosen Coovadia; Philip J R Goulder; Bette T Korber; Bruce D Walker; James I Mullins
Journal:  AIDS Res Hum Retroviruses       Date:  2009-03       Impact factor: 2.205

8.  CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individuals.

Authors:  Sunil K Ahuja; Hemant Kulkarni; Gabriel Catano; Brian K Agan; Jose F Camargo; Weijing He; Robert J O'Connell; Vincent C Marconi; Judith Delmar; Joseph Eron; Robert A Clark; Simon Frost; Jeffrey Martin; Seema S Ahuja; Steven G Deeks; Susan Little; Douglas Richman; Frederick M Hecht; Matthew J Dolan
Journal:  Nat Med       Date:  2008-03-30       Impact factor: 53.440

9.  Host genetic factors associated with symptomatic primary HIV infection and disease progression among Argentinean seroconverters.

Authors:  Romina Soledad Coloccini; Dario Dilernia; Yanina Ghiglione; Gabriela Turk; Natalia Laufer; Andrea Rubio; María Eugenia Socías; María Inés Figueroa; Omar Sued; Pedro Cahn; Horacio Salomón; Andrea Mangano; María Ángeles Pando
Journal:  PLoS One       Date:  2014-11-18       Impact factor: 3.240

10.  Association of HLA-A, B, DRB1 alleles and haplotypes with HIV-1 infection in Chongqing, China.

Authors:  Xia Huang; Hua Ling; Wei Mao; Xianbin Ding; Quanhua Zhou; Mei Han; Fang Wang; Lei Cheng; Hongyan Xiong
Journal:  BMC Infect Dis       Date:  2009-12-12       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.